These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6542568)

  • 1. High-performance liquid chromatographic assay for prostaglandin E1 in various ointment vehicles. Separation and stability testing.
    Yamamura K; Yotsuyanagi T
    J Chromatogr; 1984 Oct; 303(1):165-72. PubMed ID: 6542568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of prostaglandins A1 and B1 in alprostadil (PGE1) by high-performance liquid chromatography.
    Zoutendam PH; Bowman PB; Rumph JL; Ryan TM
    J Chromatogr; 1984 Jan; 283():281-7. PubMed ID: 6538575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of prostaglandins E1, A1, and B1 by reversed-phase high-performance liquid chromatography for the kinetic studies of prostaglandin E1 in solution.
    Lee KC; DeLuca PP
    J Chromatogr; 1991 Aug; 555(1-2):73-80. PubMed ID: 1783631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay of antiinflammatory drugs incorporated in gel ointments. Separation and stability testing.
    Yamamura K; Yamada J; Yotsuyanagi T
    J Chromatogr; 1985 Sep; 331(2):383-8. PubMed ID: 3932443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High performance liquid chromatography and UV detection for the separation and quantitation of prostaglandins.
    Terragno A; Rydzik R; Terragno NA
    Prostaglandins; 1981 Jan; 21(1):101-12. PubMed ID: 6894197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of alprostadil (PGE) in bulk drug and pharmaceutical formulations by high-performance liquid chromatography.
    Zoutendam PH; Bowman PB; Ryan TM; Rumph JL
    J Chromatogr; 1984 Jan; 283():273-80. PubMed ID: 6538574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of some prostaglandin derivatives of the sub-groups E2, A2 and B2 by high-performance liquid chromatography.
    Amin M
    J Chromatogr; 1987 Sep; 404(2):385-90. PubMed ID: 3478343
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of A, B, E, and F prostaglandins as pentafluorobenzyl esters by electron-capture gas-liquid chromatography.
    Skrinska VA; Butkus A
    Prostaglandins; 1978 Oct; 16(4):571-82. PubMed ID: 725087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and quantification of prostaglandins E1 and E2 as their panacyl derivatives using reverse phase high pressure liquid chromatography.
    Krakauer KA; Williamson PK; Baker DG; Zurier RB
    Prostaglandins; 1986 Aug; 32(2):301-10. PubMed ID: 3099332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why does a hydrophilic drug permeate skin, although it is not soluble in white petrolatum?
    Ishii H; Todo H; Terao A; Hasegawa T; Akimoto M; Oshima K; Sugibayashi K
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1356-63. PubMed ID: 19832636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of the stability of sisomicin in hydrophilic petrolatum ointment.
    Yamamura K; Nakao M; Yamada J; Yotsuyanagi T
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3632-6. PubMed ID: 6671223
    [No Abstract]   [Full Text] [Related]  

  • 12. PREPARATION AND PROPERTIES OF BENTONE OINTMENT BASES.
    BILLUPS NF; SAGER RW
    Am J Pharm Sci Support Public Health; 1964; 136():183-205. PubMed ID: 14239447
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment-Distribution of Hydrocarbon.
    Ashizuka Y; Otoguro S; Horisawa E
    Chem Pharm Bull (Tokyo); 2021; 69(4):352-359. PubMed ID: 33790080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of Bases for External Medicines with Different Coatability and Water Retentivity on Wound Healing].
    Yamada Y; Ueda Y; Ashizuka Y; Hashimoto K; Tabara K; Kitano T; Fujikawa M; Kumagai Y; Matsumoto T
    Yakugaku Zasshi; 2018; 138(11):1417-1424. PubMed ID: 30381650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment].
    Ashizuka Y; Horisawa E
    Yakugaku Zasshi; 2016 Aug; 136(8):1161-9. PubMed ID: 27193304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC.
    Amin M
    Pharm Acta Helv; 1989; 64(2):45-50. PubMed ID: 2717650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of postherpetic neuralgia by topical application of prostaglandin E1-vaseline mixture--a single blind controlled clinical trial].
    Tamakawa S; Tsujimoto J; Iharada A; Ogawa H
    Masui; 1999 Mar; 48(3):292-4. PubMed ID: 10214018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined therapy with prostaglandin E1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Bürger's disease].
    Shirakawa J; Horikawa Y; Yaku H; Takeshi M; Obara H
    Masui; 1992 Jun; 41(6):1000-3. PubMed ID: 1613942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of corticoids from oleaginous ointment bases containing drug in suspension.
    Chowhan ZT; Pritchard R
    J Pharm Sci; 1975 May; 64(5):754-9. PubMed ID: 1151642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.